Biofield tries again with breast cancer detector
This article was originally published in Clinica
Executive Summary
Biofield, a small US company which failed in an earlier attempt to commercialise a non-invasive breast cancer test, plans to relaunch the product in Europe later this year. The device, an electrical depolarisation test designed for use as an adjunct to mammography or physical examination in younger women with suspicious palpable breast lesions, has resumed CE-mark certification. The company has recertified to ISO 9001.